List view / Grid view

News

Roche acquires in vitro diagnostics company GeneWEAVE

13 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review

Roche has announced the acquisition of GeneWEAVE BioSciences Inc. to strengthen its offering in the field of microbiology diagnostics.

Improved membrane chromatography performance

12 August 2015 | By Sartorius

Redesigned Sartobind® membrane adsorber capsules offer higher binding capacities, reduced void volumes, less buffer consumption and lower operational costs...

Positive results from pivotal Phase II study of venetoclax

12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review

Roche have announced positive results from the Phase II M13-982 study of venetoclax, an investigational medicine developed for hard-to-treat chronic lymphocytic leukaemia.

Magnetic blood filter to tackle drug resistant malaria

12 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review

A magnetic blood filtering device is under development by start-up company MediSieve to capture and remove red blood cells infected with drug resistant malaria.

Medimmune and Inovio Pharmaceuticals agree to DNA-based immunotherapy collaboration

11 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a license agreement and collaboration with Inovio Pharmaceuticals, a biotechnology company developing DNA-based immunotherapies for cancer and infectious diseases.

DKSH signs agreement with Actelion to drive growth in Asia

11 August 2015 | By Katie Sadler, Digital Content Producer, European Pharmaceutical Review

DKSH, the Market Expansion Services provider with a focus on Asia, and Actelion Pharmaceuticals Singapore PTE Ltd, an affiliate of Actelion Ltd, a global biopharmaceutical company, have started a collaboration to support the business growth in Asia.

New solutions for aptamer applications in Europe

7 August 2015 | By Eurogentec

Eurogentec s.a. and NeoVentures Biotechnology Inc. are pleased to announce that they have entered into a business alliance to stimulate the development of aptamer applications in Europe...